Sona De

March 27, 2023 | New York Law Journal

The president directed the U.S. Food and Drug Administration (FDA) and the U.S. Patent and Trademark Office (PTO) to propose ways the two agencies could collaborate towards this end. The agencies responded with a joint proposal to change how patents protecting drugs are examined, prompting responses from a wide range of industry participants.

By Sona De and Steven Horowitz

8 minute read